Teplizumab improves and stabilizes beta cell function in antibody-positive high-risk individuals.
Sims EK, Bundy BN, Stier K, Serti E, Lim N, Long SA, Geyer SM, Moran A, Greenbaum CJ, Evans-Molina C, Herold KC; Type 1 Diabetes TrialNet Study Group.
Sims EK, et al.
Sci Transl Med. 2021 Mar 3;13(583):eabc8980. doi: 10.1126/scitranslmed.abc8980.
Sci Transl Med. 2021.
PMID: 33658358
Free PMC article.
Clinical Trial.